Correction to: Adv Ther https://doi.org/10.1007/s12325-021-01748-0

In Table 2 of the original article the ‘Route of administration’ for ‘Semaglutide’ was published incorrectly. The route of administration was published as ‘Oral’. The correct route of administration should be subcutaneous. The correct Table 2 is given below:

Table 2 Summary of dosing regimens of available and investigational weight management pharmacotherapies

The original article has been corrected.